Question 1

What is Spyre Therapeutics?

Accepted Answer

Spyre Therapeutics is a Company.

Question 2

How often does Spyre Therapeutics appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 14 articles.

Question 3

When was Spyre Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Apr 10, 2026.

Question 4

When was Spyre Therapeutics last mentioned in news?

Accepted Answer

Last active on Jul 02, 2026.

Question 5

What is Spyre Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 15 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Spyre Therapeutics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Spyre Therapeutics?

Accepted Answer

Spyre Therapeutics Upsized Public Offering (Apr 13, 2026, 7 articles).

Question 8

How did the "Spyre Therapeutics Upsized Public Offering" event impact Spyre Therapeutics?

Accepted Answer

Spyre Therapeutics commenced and priced an underwritten public offering of its common stock, raising approximately $403.0 million in gross proceeds to fund its operations and development of treatments for Inflammatory Bowel Disease and other immune-mediated diseases.

Question 9

How did the "Spyre Therapeutics Grants Inducement Awards" event impact Spyre Therapeutics?

Accepted Answer

Spyre Therapeutics granted stock options and restricted stock units to new non-executive employees as inducement awards, which is a common practice to attract talent and could positively impact the company's future performance by securing skilled personnel.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.